SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of WuXia293 Stable ...

Demeetra AgBio (Demeetra) today announced the publication of a peer-reviewed research article in Biotechnology Progress validating the performance of its integrated cell line development (CLD) ...

LAUSANNE, Switzerland, Feb. 18, 2026 (GLOBE NEWSWIRE) -- NewBiologix S.A., a biotechnology company advancing recombinant adeno-associated virus (rAAV) production through next-generation clonal HEK293 ...

The full-length human TL1A (Uniprot: O95150-1) is expressed by the HEK293/Human TL1A Stable Cell Line. Using flow cytometry, the surface expression of human TL1A was verified.

The collaboration integrates Demeetra’s CleanCut CHO platforms and cell line services with NorthX Biologics’ GMP manufacturing expertise.

Proteomics-informed, genome-edited CHO design increased productivity up to three-fold and titers two-fold, strengthening CLD for novel biologics and biosimilars. Extended culture robustness was ...

NorthX Biologics and Demeetra are collaborating to help biotech companies reach Investigational New Drug and clinical ...

Sartorius has launched a new genetically engineered CHO host cell line designed to improve productivity and efficiency.

Gene therapies offer incredible promise for treating diseases with a genetic component. Several gene therapies are already available, and adeno-associated virus (AAV) has become a popular choice for ...

Non-viral, DSB-free integration: ABBIE employs a dCas9-integrase fusion to guide targeted, donor-DNA integration while avoiding double-strand breaks and viral delivery. SOHM is a biopharmaceutical ...